Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447720 · ClinicalTrials.gov registry record · Phase 3
HIV Prevention Among Substance Abusing SMI
A Phase 3 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 238
- Enrollment target
NCT00447720: Completed Phase 3 study, sponsored by University of Pennsylvania.
NCT00447720 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 238 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447720, a Phase 3 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 238 participants
- Enrollment target
Study Summary
This study seeks to examine the effectiveness of translating two proven interventions, RESPECT, and the NIDA Community Based Outreach Model, into one program of education, PATH, to be delivered by case managers to their seriously mentally ill, substance abusing clients. The objective is to teach case managers to assess the specific risk profiles of their clients, and then create a plan of intervention aimed at reducing high risk sexual and substance abusing behaviors.
Interventions
- BEHAVIORAL PATH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2004-06 |
| Est. Completion | 2008-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00447720
The ClinicalTrials.gov registry entry for NCT00447720 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PATH is the first listed.
NCT00447720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00447720 about?
NCT00447720 is a clinical study titled "HIV Prevention Among Substance Abusing SMI". This study seeks to examine the effectiveness of translating two proven interventions, RESPECT, and the NIDA Community Based Outreach Model, into one program of education, PATH, to be delivered by case managers to their seriously mentally ill, substance abusing clients. The objective is to teach ca...
What is the current status of trial NCT00447720?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 238 participants. The study started on 2004-06. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00447720?
The interventions under investigation include: PATH (BEHAVIORAL).
Who is sponsoring clinical trial NCT00447720?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.